与重组活化因子VII相比，使用凝血酶原复合物浓缩物进行华法林逆转可赋予更好的抗纤维蛋白溶解活性。 - Suppr

Suppr

超能文献

Warfarin reversal with prothrombin complex concentrate confers better antifibrinolytic activity compared with recombinant activated factor VII.

作者信息

Taketomi Taro, Szlam Fania, Levy Jerrold H, Tanaka Kenichi A

出版信息

Blood Coagul Fibrinolysis. 2008 Jan;19(1):106-8. doi: 10.1097/MBC.0b013e3282f185c9.

DOI:10.1097/MBC.0b013e3282f185c9

PMID:18180627

Abstract

摘要

相似文献

Warfarin reversal with prothrombin complex concentrate confers better antifibrinolytic activity compared with recombinant activated factor VII.

Blood Coagul Fibrinolysis. 2008 Jan;19(1):106-8. doi: 10.1097/MBC.0b013e3282f185c9.

Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro.

Thromb Res. 2014 Apr;133(4):671-81. doi: 10.1016/j.thromres.2014.01.017. Epub 2014 Jan 21.

Comparative effectiveness of hemostatic therapy in experimental warfarin-associated intracerebral hemorrhage.

Stroke. 2011 Jan;42(1):191-5. doi: 10.1161/STROKEAHA.110.593541. Epub 2010 Dec 2.

Reversal of new, factor-specific oral anticoagulants by rFVIIa, prothrombin complex concentrate and activated prothrombin complex concentrate: a review of animal and human studies.

Thromb Res. 2014 May;133(5):705-13. doi: 10.1016/j.thromres.2014.01.031. Epub 2014 Jan 31.

Effects of recombinant activated factor VII on thrombin-mediated feedback activation of coagulation.

Blood Coagul Fibrinolysis. 2008 Mar;19(2):135-41. doi: 10.1097/MBC.0b013e3282f41e6d.

Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood.

Anesth Analg. 2012 Jun;114(6):1182-8. doi: 10.1213/ANE.0b013e31823b6683. Epub 2011 Nov 21.

More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate.

Thromb Res. 2015 Mar;135(3):544-7. doi: 10.1016/j.thromres.2014.12.019. Epub 2015 Jan 2.

Reversal of dabigatran effects in models of thrombin generation and hemostasis by factor VIIa and prothrombin complex concentrate.

Anesthesiology. 2015 Feb;122(2):353-62. doi: 10.1097/ALN.0000000000000540.

Rapid reversal of warfarin-associated hemorrhage in the emergency department by prothrombin complex concentrates.

Ann Emerg Med. 2013 Dec;62(6):616-626.e8. doi: 10.1016/j.annemergmed.2013.05.026. Epub 2013 Jul 3.

A direct thrombin inhibitor studied by dynamic whole blood clot formation. Haemostatic response to ex-vivo addition of recombinant factor VIIa or activated prothrombin complex concentrate.

Thromb Haemost. 2006 Oct;96(4):446-53.

引用本文的文献

The epidemic of pre-injury oral antiplatelet and anticoagulant use.

Eur J Trauma Emerg Surg. 2014 Dec;40(6):657-69. doi: 10.1007/s00068-014-0404-9. Epub 2014 May 1.

Anticoagulation-related intracranial hemorrhages.

Curr Atheroscler Rep. 2012 Aug;14(4):351-9. doi: 10.1007/s11883-012-0258-8.

Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy.

Int J Emerg Med. 2009 Nov 26;2(4):217-25. doi: 10.1007/s12245-009-0125-8.

Prothrombin complex concentrates for oral anticoagulant therapy-related intracranial hemorrhage: a review of the literature.

Neurocrit Care. 2010 Jun;12(3):403-13. doi: 10.1007/s12028-009-9310-0.

Prothrombin complex concentrate (Beriplex P/N).

Drugs. 2009 Oct 1;69(14):1977-84. doi: 10.2165/11203690-000000000-00000.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验